These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6722646)

  • 1. The activated partial thromboplastin time of diluted plasma: variability due to the method of fibrin detection.
    Johnstone IB
    Can J Comp Med; 1984 Apr; 48(2):198-201. PubMed ID: 6722646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombokinetic studies in normal and factor VIII-deficient canine plasmas.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):157-62. PubMed ID: 6603892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of factor VIII:C activity on the activated partial thromboplastin time (aPTT) in the dog. Adaptation of the aPTT as a screening test for canine hemophilia A?].
    Mischke R
    Dtsch Tierarztl Wochenschr; 1993 Jun; 100(6):219-22. PubMed ID: 8339706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
    Johnstone IB; Martin CA
    Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of prothrombin time and activated partial thromboplastin time in dogs with hepatic disease.
    Badylak SF; Van Vleet JF
    Am J Vet Res; 1981 Dec; 42(12):2053-6. PubMed ID: 7340574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemophilia A in the dog: symptoms, blood coagulation analysis and treatment].
    Mischke R; Rivera Ramirez PA; Deniz A; Hänies R; Otto K
    Berl Munch Tierarztl Wochenschr; 1996 Aug; 109(8):279-87. PubMed ID: 9005837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data.
    Hirai N; Tatsumi N; Hino M; Yamane T; Ohta K
    Osaka City Med J; 1998 Jun; 44(1):55-71. PubMed ID: 9834619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
    Hellebrekers LJ; Slappendel RJ; van den Brom WE
    Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-based blood coagulation assay device for measuring activated partial thromboplastin time.
    Dudek MM; Kent N; Gustafsson KM; Lindahl TL; Killard AJ
    Anal Chem; 2011 Jan; 83(1):319-28. PubMed ID: 21121686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of the global coagulation tests for the dog. Significance for the monitoring of heparin therapy].
    Mischke R; Nolte I
    Tierarztl Prax; 1991 Oct; 19(5):561-6. PubMed ID: 1759273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of citrate concentration on coagulation test results in dogs.
    Stokol T; Brooks MB; Erb HN
    J Am Vet Med Assoc; 2000 Dec; 217(11):1672-7. PubMed ID: 11110458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of high-concentration calcium chloride solution for correction of activated partial thromboplastin time (APTT) in patients with high-hematocrit value.
    Kanahara M; Kai H; Okamura T; Wada T; Suda K; Imaizumi T; Sagawa K
    Thromb Res; 2008; 121(6):781-5. PubMed ID: 17904620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Applicability of activated partial thromboplastin time (APTT) as a screening test of milk to medium deficiencies of coagulation factors in cats].
    Deniz A; Mischke R; Nolte I
    Dtsch Tierarztl Wochenschr; 1995 May; 102(5):206-8. PubMed ID: 8593777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of haemolysis, lipaemia and bilirubinaemia on prothrombin time, activated partial thromboplastin time and thrombin time in plasma samples from healthy dogs.
    Moreno P; Ginel PJ
    Res Vet Sci; 1999 Dec; 67(3):273-6. PubMed ID: 10607508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C).
    Shima M; Matsumoto T; Fukuda K; Kubota Y; Tanaka I; Nishiya K; Giles AR; Yoshioka A
    Thromb Haemost; 2002 Mar; 87(3):436-41. PubMed ID: 11916076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated coagulation time in monitoring heparinized dogs.
    Green RA
    Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT) on canine citrated plasma samples following different storage conditions.
    Rizzo F; Papasouliotis K; Crawford E; Dodkin S; Cue S
    Res Vet Sci; 2008 Aug; 85(1):166-70. PubMed ID: 17998140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of mild factor VIII Deficiency by thrombokinetics.
    Natelson EA; Shapiro D; Smith DF
    Am J Clin Pathol; 1975 Jul; 64(1):95-100. PubMed ID: 1155379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyophilised plasmas for one-stage determination of factor VIII.
    Sikorová J; Vorlová Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(6):906-13. PubMed ID: 6162757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.